TDS, TCS, and Annual Filings for FY 2025-26: India's Tax Compliance Deadlines for April & May 2026

Tax & Accounting

FY 2026-27 represents a transition in India’s tax compliance calendar, with the new framework taking effect April 1. Businesses and investors face a dual-responsibility period: closing out obligations for the previous year under the old law while adopting new reporting structures for current transactions.

Human Resources & Payroll

Rethinking Payroll Under India's Income Tax Rules 2026: Employer Accountability in Salary and TDS

Ensure your payroll is compliant with India’s Income Tax Rules, 2026, effective April 1. Learn more about new TDS norms, HRA documentation, and perquisite valuation under the Income-tax Act, 2025.

Tax & Accounting

A Guide to India’s TDS Rates for FY 2025-26

We explore India's updated tax deducted at source (TDS) rates and threshold changes for FY 2025–26 as per the Finance Act 2025, including detailed section-wise rates, compliance updates, and key tax reforms.

Economy & Trade

India's Union Budget 2026-27: Industrial Growth, Infrastructure Spending, Tax Reforms, and What Global Investors Need to Know

India’s Union Budget 2026–27 outlines major manufacturing incentives, infrastructure capex, tax simplification, and investor facilitation. Key takeaways for global investors.

Get free access to our subscriptions and publications

Subscribe to receive weekly India Briefing news updates, our latest doing business publications, and access to our Asia archives.

Sign Up Now
India Briefing

Economy & Trade

Economy & Trade

US Pharma Tariff 2026: Decoding the 100% Patented Drug Levy and the Generic Exemption

Apr 03

The US administration under President Donald J. Trump has implemented a 100% tariff on patented pharma products to curb import dependence. While Indian generics are exempt for now, a one-year review and API onshoring rules signal long-term shifts.

 

Tax & Accounting

Tax & Accounting

TDS, TCS, and Annual Filings for FY 2025-26: India's Tax Compliance Deadlines for April & May 2026

Apr 06

FY 2026-27 represents a transition in India’s tax compliance calendar, with the new framework taking effect April 1. Businesses and investors face a dual-responsibility period: closing out obligations for the previous year under the old law while adopting new reporting structures for current transactions.

 

Legal & Regulatory

Legal & Regulatory

Remote Work in India: Legal Framework, Employee Rights, and Compliance Guide for Employers

Apr 02

Navigate WFH and remote work compliance in India under the new 2026 Labor Codes. Learn about employer obligations for payroll, provident fund (PF), tax, and employee rights.

Industries

Industries

US Pharma Tariff 2026: Decoding the 100% Patented Drug Levy and the Generic Exemption

Apr 03

The US administration under President Donald J. Trump has implemented a 100% tariff on patented pharma products to curb import dependence. While Indian generics are exempt for now, a one-year review and API onshoring rules signal long-term shifts.

 

HR & Payroll

HR & Payroll

Remote Work in India: Legal Framework, Employee Rights, and Compliance Guide for Employers

Apr 02

Navigate WFH and remote work compliance in India under the new 2026 Labor Codes. Learn about employer obligations for payroll, provident fund (PF), tax, and employee rights.

 

Expert Guidance about Business in Asia

Dezan Shira & Associates is a pan-Asia, multi-disciplinary professional services firm, providing market entry, legal, accounting, tax, HR, technology and operational advisory to international investors.

Business Updates for All Asia Markets

Asia Briefing publishes articles, magazines, and guides on doing business in Asia. Dezan Shira & Associates has produced the publication since 1999.

About Asia Briefing Ask Us a Question

Need More Guidance?

India Briefing Publications

Download magazines and guides on doing business in India.

Download Now
Back to top